Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBMNC and Pulmonary Surfactant for BPD in Preterms
NCT03855202Phase 1Unknown
- Start
- Feb 2019
- Primary completion
- Aug 2019
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, randomised trial of autologous umbilical cord blood-derived mononuclear cells in bronchopulmonary dysplasia (BPD) (4 arms). Primary endpoint: Number of patients who died at 21 days. Status: unknown.
02
Drugs
autologous umbilical cord blood-derived mononuclear cells
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT03855202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03855202.